Zenaida Mojares

Zenaida Mojares

Director Técnico/Científico/I+D en YS BIOPHARMA CO., LTD. .

65 años
Consumer Services
Health Technology
Commercial Services

Perfil

Zenaida Reynoso Mojares is currently the Chief Medical Officer at YS Biopharma Co. Ltd.
She previously worked as the Regional Director-Medical at Takeda Pharmaceuticals International AG from 2017 to 2020, as the Chief Medical Officer at GlaxoSmithKline Pte Ltd.
in 2015-2016, and as the Chief Medical Officer at the International Vaccine Institute from 2020 to 2022.
Dr. Mojares received her undergraduate degree from the University of Santo Tomas in 1979, her graduate degree from the University of the Philippines in 2004, her graduate degree from the University of Siena in 2011, and her doctorate from the University of Perpetual Help System Dalta in 1990.

Cargos activos de Zenaida Mojares

EmpresasCargoInicio
YS BIOPHARMA CO., LTD. Director Técnico/Científico/I+D 01/01/2022
Todos los cargos activos de Zenaida Mojares

Antiguos cargos conocidos de Zenaida Mojares.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/01/2022
Corporate Officer/Principal 01/07/2020
Director Técnico/Científico/I+D 01/02/2016
Ver el detalle de la experiencia de Zenaida Mojares.

Formación de Zenaida Mojares.

University of Santo Tomas Undergraduate Degree
University of Perpetual Help System Dalta Doctorate Degree
University of Siena Graduate Degree
University of the Philippines Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Zenaida Mojares.

Relaciones

64

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
YS BIOPHARMA CO., LTD.

Health Technology

Empresas privadas3

Commercial Services

Health Technology

Health Technology

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA